Opendata, web and dolomites

MetD-AO SIGNED

Methyl Donating artificial organelles to support liver cells in Non-alcoholic fatty liver disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MetD-AO project word cloud

Explore the words cloud of the MetD-AO project. It provides you a very rough idea of what is the project "MetD-AO" about.

characterization    me    oxygen    latter    acrylate    tail    world    synthetase    cellular    adenosylmethionine    intracellular    gaining    artificial    chemist    successful    escape    carboxypentyl    carrier    medical    donating    aos    therapeutic    prior    membranolytic    consisting    colloidal    western    substitute    career    cytosol    biology    reactors    methyl    release    science    synth    lysosome    hepatocytes    nano    function    polymer    ao    methacrylate    lysosomal    failing    nonalcoholic    conduction    cholesterol    assemble    disease    organic    functional    homeostasis    missing    metd    cell    assembly    liver    enzyme    reported    nafld    copolymers    deficiencies    spectrum    perform    multiple    structurally    host    nanoparticles    biocatalytic    compartment    self    mimicking    trained    organelles    fatty    lost    poly    intact    chronic    hydrophilic    few    cargo    entirely    dr    sized    pharmaceutical    respectively    protein    biosynthesis    reactive    encompassing    started    destroyed    vitro    single    amphiphilic    expertise    reaction    preserving    prospects    damage    complementary    encapsulated    stadler    employing    outcome   

Project "MetD-AO" data sheet

The following table provides information about the project.

Coordinator
AARHUS UNIVERSITET 

Organization address
address: NORDRE RINGGADE 1
city: AARHUS C
postcode: 8000
website: www.au.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 219˙312 €
 EC max contribution 219˙312 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AARHUS UNIVERSITET DK (AARHUS C) coordinator 219˙312.00

Map

 Project objective

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, encompassing a spectrum of liver damage. Multiple issues are involved on the cellular level in failing liver often including enzyme deficiencies such as reduced biosynthesis of S-adenosylmethionine (SAMe). Preserving SAMe homeostasis has only recently started to be considered as a potential therapeutic target in liver-related medical conditions. However, employing the required enzyme, SAMe synthetase (SAMe-synth), as a pharmaceutical, is challenging due to the general issues involved in intact (functional) protein delivery. The aim of the MetD-AO project is to assemble organic SAMe-synth activity mimicking polymer nanoparticles as artificial organelles (AO) and their in vitro characterization of intracellular function in hepatocytes. AOs are typically nano-sized single compartment reactors, aimed to perform a specific encapsulated biocatalytic reaction within a cell to substitute for missing or lost function. The AO will be based on amphiphilic copolymers consisting of a methyl-donating unit, cholesterol methacrylate and poly(5-carboxypentyl acrylate) as membranolytic hydrophilic tail. The latter two will aim at facilitating self-assembly and lysosomal escape, respectively. To allow structurally intact AO to escape the lysosome is unique since typically, the carrier is destroyed and only the therapeutic cargo is release into the cytosol. The proposed AOs with methyl-donating ability are highly advanced because the few prior reported AOs with intracellular activity all considered reactive oxygen related aspects at best. The successful outcome of MetD-AO has the potential to open up entirely new therapeutic opportunities in NAFLD. The complementary expertise of my host Dr. Stadler and me, a trained polymer chemist, will ensure a successful conduction of MetD-AO while it will enhance my future career prospects gaining experience in colloidal science and cell biology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METD-AO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METD-AO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MarshFlux (2020)

The effect of future global climate and land-use change on greenhouse gas fluxes and microbial processes in salt marshes

Read More  

STIMOS (2019)

Stimulation of Multiple Organoids Simultaneously

Read More  

BIOplasma (2019)

Use flexible Tube Micro Plasma (FµTP) for Lipidomics

Read More